DZ Bank Bonus Zert MRK 27.09.2024/ DE000DJ3W6L4 /
2024-06-20 8:34:21 PM | Chg.+0.100 | Bid9:27:27 PM | Ask9:27:27 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
138.040EUR | +0.07% | 138.040 Bid Size: 250 |
138.090 Ask Size: 250 |
MERCK KGAA O.N. | - EUR | 2024-09-27 | Call |
GlobeNewswire
6:31 PM
Pioneering Support for Working Parents: INVNT GROUP Becomes First Global Agency to Partner with Milk...
GlobeNewswire
4:00 PM
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
1:30 PM
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confe...
GlobeNewswire
06-03
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA